Zhang and colleagues found that multiple myeloma-derived EVs expressing miR-103a-3p inhibited osteogenesis in bone marrow-derived mesenchymal stem cells (BMSCs) and increased IL-6 secretion in multiple myeloma cells, resulting in impaired osteogenesis and exacerbated bone metastasis (61). Here, IL6 is linked to plasma cell myeloma.